November 7, 2026

Pharmaceutical company AbbVie has expanded its research and development facilities in Oxford as part of more than £120m invested and committed to scientific research, academic collaboration and talent development across...

Life Sciences, Physics & Engineering

Biotechnology, Golden Triangle, Immunology, inflammatory disease, Investment, Lab build, Molecular science, Neuroscience, Oncology, R&D